Drug
Itolizumab
Itolizumab: highest development phase Phase 3, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Itolizumab NCT05263999 | Phase 3 | Graft Versus Host Disease |
Latest
No recent events.
Follow Itolizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.